tradingkey.logo
tradingkey.logo
Buscar

MiMedx Group Inc

MDXG
Añadir a la lista de seguimiento
3.600USD
-0.090-2.44%
Cierre 05/08, 16:00ETCotizaciones retrasadas 15 min
536.20MCap. mercado
17.32P/E TTM

MiMedx Group Inc

3.600
-0.090-2.44%

Más Datos de MiMedx Group Inc Compañía

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

Información de MiMedx Group Inc

Símbolo de cotizaciónMDXG
Nombre de la empresaMiMedx Group Inc
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)
Número de empleados837
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 20
Dirección1775 W Oak Commons Court, Ne
CiudadMARIETTA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal30062
Teléfono17706519100
Sitio Webhttps://mimedx.com/
Símbolo de cotizaciónMDXG
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)

Ejecutivos de MiMedx Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
900.62K
+41.20%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+13.45%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
202.46K
+36.63%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+15.73%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
119.71K
+74.33%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+49.67%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
900.62K
+41.20%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+13.45%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
202.46K
+36.63%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+15.73%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
119.71K
+74.33%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+49.67%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
276.33M
66.01%
Surgical
142.30M
33.99%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
276.33M
66.01%
Surgical
142.30M
33.99%

Estadísticas de accionistas

Actualizado: hace 16 horas
Actualizado: hace 16 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
EW Healthcare Partners
18.93%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
4.14%
Vanguard Capital Management, LLC
3.47%
State Street Investment Management (US)
2.56%
Otro
65.00%
Accionistas
Accionistas
Proporción
EW Healthcare Partners
18.93%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
4.14%
Vanguard Capital Management, LLC
3.47%
State Street Investment Management (US)
2.56%
Otro
65.00%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
24.92%
Investment Advisor/Hedge Fund
19.89%
Venture Capital
18.93%
Hedge Fund
11.86%
Individual Investor
1.94%
Research Firm
1.91%
Pension Fund
0.50%
Bank and Trust
0.38%
Insurance Company
0.02%
Otro
19.65%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
462
116.77M
78.40%
+6.17M
2025Q4
457
106.79M
72.11%
-2.86M
2025Q3
443
104.90M
70.83%
-3.83M
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
EW Healthcare Partners
28.20M
18.98%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
8.79M
5.92%
+60.63K
+0.69%
Dec 31, 2025
Trigran Investments, Inc.
6.16M
4.15%
-1.54M
-19.97%
Dec 31, 2025
State Street Investment Management (US)
3.81M
2.57%
+219.19K
+6.10%
Dec 31, 2025
First Light Asset Management, LLC
3.04M
2.05%
-613.61K
-16.80%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.84M
1.91%
-2.26K
-0.08%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.48M
1.67%
+97.04K
+4.07%
Dec 31, 2025
Renaissance Technologies LLC
2.47M
1.66%
+458.84K
+22.85%
Dec 31, 2025
Paradigm Capital Management, Inc.
2.45M
1.65%
-200.00K
-7.54%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.58%
Janus Henderson Small Cap Growth Alpha ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.3%
iShares Micro-Cap ETF
0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.16%
Franklin US Small Cap Multifactor Index ETF
0.15%
Vanguard US Quality Factor ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
State Street SPDR S&P Biotech ETF
0.12%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.58%
Janus Henderson Small Cap Growth Alpha ETF
Proporción0.56%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.3%
iShares Micro-Cap ETF
Proporción0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.16%
Franklin US Small Cap Multifactor Index ETF
Proporción0.15%
Vanguard US Quality Factor ETF
Proporción0.14%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.12%
State Street SPDR S&P Biotech ETF
Proporción0.12%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI